Work Under Way To Develop Super COVID-19 Vaccine

Share on facebook
Facebook
Share on twitter
Twitter

Assistant Director of the Pan American Health Organization (PAHO), Dr. Jarbas Barbosa da Silva Jr., says work is under way by researchers to develop a universal or ‘super’ coronavirus (COVID-19) vaccine.

It is anticipated that the proposed vaccine will be very effective against all COVID-19 variants and provide permanent protection against the disease.

“We have several candidates [undertaking this research], but they are still in the preclinical… lab-testing phase. We will  eventually have some clinical trials,” Dr. Barbosa said.

He was speaking during PAHO’s weekly COVID-19 digital media briefing on Wednesday (February 9).

Reports emerging out of the United States last week indicated that the military has been undertaking the development of  a ‘pan-coronavirus vaccine’ – the spike ferritin nanoparticle (SpFN) – for which phase-one human trials have been completed.

The report indicated that the vaccine is being tested against all COVID-19 variants, including Omicron.

Dr. Barbosa emphasised that while super vaccine development is awaited, “let us use [those] that we have”.

“The vaccines that are available now are [also] ‘super vaccines’. They have saved and are still saving millions of lives all over the world. They can reduce serious cases [and] deaths,” he added.

The Assistant Director said this has been proven by the data provided by countries across the region of the Americas and globally, “so let us continue to use [those vaccines]”.

See also  Jamaica to get Johnson & Johnson Vaccines
Scroll to Top